Surgical oncologists face the challenge of managing gastrointestinal midgut neuroendocrine neoplasms (NENs), particularly neuroendocrine tumors (NETs). While guidelines offer valuable insights, they rely on expert opinions and retrospective evidence. This review outlines recent recommendations for managing midgut NETs, emphasizing the need for individualized approaches based on tumor behavior, endocrine syndrome association, and prognosis. Staying updated on evolving therapies and tumor understanding is crucial for optimal patient care.
Journal Article by Hallet J and Clarke CN in Ann Surg Oncol
© 2023. Society of Surgical Oncology.